SaNOtize Research and Development retweeted
RETURNING MEMBER: @SanotizeD is a Vancouver-based biotechnology company that has developed a proprietary method to deliver nitric oxide to the site of infection effectively. They are also developing products for other healthcare applications.
Learn more:
ow.ly/ihjX50PFHR2
Exciting news! We’ve given our website a refresh – it’s got a new look and more information about what we do, why we do it, and the reasons to be excited about the promise of nitric oxide.
Please visit us at sanotize.com
#WebsiteRedesign #nitricoxide #innovation
SaNOtize Research and Development retweeted
LSBC JOB BOARD: @SanotizeD is seeking two full-time positions. Learn more about the positions below:
Director of Clinical Affairs: lifesciencesbc.ca/job/direct…
Director of Regulatory Affairs: lifesciencesbc.ca/job/direct…
ECRAID-Prime and SaNOtize Research and Development Corp. have signed a collaboration agreement to begin the first study of SaNOtize’s antiviral nitric oxide nasal spray (NONS), using Europe’s adaptive platform trial in primary care.
ecraid.eu/news/ecraid-prime-…
SaNOtize Research and Development retweeted
Nitric oxide nasal spray by @SanotizeD is being touted as an innovative anti-viral spray, proven effective in preventing viruses, including #COVID19 from entering the nasal cavity.
@ShrutiMishra_ talks to Co-founder Chris Miller to find out more.
@OurCrowd #Enovid #NoseSanitizer
Gilly Regev is featured in @Medium's series "Why We
Need More Women Founders,” in which she discusses the story of SaNOtize and the challenges she overcame to get to where she is today. Read the interview here:
medium.com/authority-magazin…
#interview #womenempowerment
We’re celebrating International Day of Women and Girls in Science with our own Dr. Gilly Regev! Her 20+ years in scientific research and development set an aspirational example of perseverance as a woman in STEM. #February11 #InternationalDayofWomenandGirlsinScience
Exciting news! Our inaugural scientific advisory board, made up of top leaders from Canada, US & Europe, will guide our innovative product pipeline, clinical development, and growth opportunities.#patientaccess #healthcareequity #advisoryboard #nitricoxide
businesswire.com/news/home/2…
"We are very excited to welcome John Sharp, who comes to SaNOtize at a transformative time in the evolution of the company,” said SaNOtize CEO and co-founder Gilly Regev, PhD.
businesswire.com/news/home/2…
SaNOtize Research and Development retweeted
𝟴 𝑑𝑎𝑦𝑠 𝑜𝑓 𝐻𝑎𝑛𝑢𝑘𝑘𝑎ℎ
𝟵 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 𝑤𝑎𝑦𝑠 𝑡𝑜 𝑠𝑝𝑒𝑙𝑙 𝑖𝑡.
𝟏𝟎 𝑚𝑜𝑟𝑒 𝑑𝑎𝑦𝑠 𝑢𝑛𝑡𝑖𝑙 𝑡ℎ𝑒 𝑒𝑛𝑑 𝑜𝑓 𝑜𝑢𝑟 ℎ𝑜𝑙𝑖𝑑𝑎𝑦 𝑑𝑖𝑠𝑐𝑜𝑢𝑛𝑡.
Seize it before the lights go out. Enter promo code OCSUMMIT20 👉 summit.ourcrowd.com/?utm_sou…
SaNOtize Research and Development retweeted
The #tech world’s most inspiring women leaders, inc @melissadrew0, of @IBM, a founding member of @wlda_tech, Gilly Regev CEO anti-Covid spray @SanotizeD, @DoleSunshine's Lara Ramdin & many more will gather at OurCrowd's global summit in Jerusalem. Register summit.ourcrowd.com/?utm_sou…
A big thanks to Viromed, our partner in Germany, who ran a very busy VirX booth at the @MEDICATradeFair in Düsseldorf this week. We look forward to our continued relationship.
#biotechnology #MEDICA2022
We congratulate this year’s @LifeSciEvents Fierce Innovation Awards: Life Sciences Edition 2022 winner, @LyndraInc for their LYNX drug delivery platform. This is a well-deserved recognition, and we are honoured to be shortlisted with you!
#FierceLifeSciencesAwards #innovation
We are excited to announce that Nitric Oxide Nasal Spray (NONS™) has been shortlisted as one of the finalists for the Fierce Innovation Awards: Life Sciences Edition 2022! We want to thank @LifeSciEvents for their consideration. #FierceLifeSciencesAwards #nitricoxide #innovation
fiercepharma.com/pharma/sano…
Fierce Pharma highlights our platform technology:
We would like to clarify a general misconception between nitrous oxide and nitric oxide, as mistakenly referenced below. These are not the same molecules and have very different effects in the body. The nitric oxide in our products acts as an anti-microbial.
Happy to announce a successful, oversubscribed funding round that will help us advance indications on our NORS platform technology.
businesswire.com/news/home/2…
SaNOtize Research and Development retweeted
The antiviral nasal spray produced by our portfolio company @SanotizeD reduces 99% of #COVID19 viral load within 48 hours of treatment, @TheLancet reports.
@glenmarkpharma
For more information on investing in SaNOtize:
hubs.ly/Q01h--_V0
SaNOtize Research and Development retweeted
NEW: @SanotizeD will test its nasal spray in the U.S. as a COVID preventative rather than early treatment after regulators pour cold water on viral load reduction as a viable primary endpoint. The company hopes to launch the ph. 3 trial in October. fiercebiotech.com/biotech/sa…















